about
New trends in breast cancer surgery: a therapeutic approach increasingly efficacy and respectful of the patientSentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy.Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial.Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER databaseImpact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient populationTumor characteristics influencing non-sentinel lymph node involvement in clinically node negative patients with breast cancer.Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapyThe feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study.The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidenceAxillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literatureSentinel lymph node biopsy for breast cancer: current controversies.Lymphatic mapping and sentinel lymph node biopsy for breast cancer patients.Micrometastatic disease and isolated tumor cells as a predictor for additional breast cancer axillary metastatic burden.Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model.The positive sentinel node.Sentinel node biopsy for breast cancer: past, present, and future.Relevance of the American College of Surgeons Oncology Group Z0011 Trial to breast cancer in the Australian setting.Questioning the role of axillary node dissection in sentinel node positive early stage breast cancer in the South Eastern Cancer Centre.Sentinel lymph node biopsy and neoadjuvant chemotherapy in breast cancer patients.Landmark clinical trials influencing surgical management of non-invasive and invasive breast cancer.Management of Early Node-Positive Breast Cancer in Australia: A Multicentre Study.Predicting Non-sentinel Lymph Node Metastasis in a Chinese Breast Cancer Population with 1-2 Positive Sentinel Nodes: Development and Assessment of a New Predictive Nomogram.The impact of preoperative axillary ultrasonography in T1 breast tumours.Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.Axillary recurrence in sentinel lymph node-negative breast cancer patients.Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast Surgeons.A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram.Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases
P2860
Q26771845-E8A412E5-D651-47B9-BCA3-83F38CCF0CE5Q31022615-E53D59E2-CBC5-4F03-8415-8E5E052A1BE8Q33705413-84CE78DC-C94F-4594-9934-41809095E2C3Q33799441-E8FD9395-E1C0-4F31-A61F-F3E35BFC37B5Q33928258-50D6E901-7599-4F2D-9811-636AD3C3A388Q35073254-A4AFB59B-1BD3-4A0C-BF2C-C127909C50CEQ35092746-7FD8D5C9-880A-4C08-99FB-AFAFE773FFDAQ35142187-159A9D65-5744-44DC-B6E7-E42E383F462FQ35194725-2D0C35E9-2657-40BB-A918-C0C5564312CBQ36168193-774AF392-07B3-4C89-B398-9DDDAEE57C44Q36190462-48094738-1478-4563-AE2D-3020CEAD9643Q36420776-F3C94EC4-0DD8-45DD-80B2-9B3F5D84193DQ36588406-A3752569-07E7-4D78-ABD4-02758C7E3E30Q37478779-A7EE6614-4E56-455C-A524-5B4FE8531947Q37482186-6587EF59-B2D3-444D-B67B-24491D768EF4Q37602556-D7186F8E-F4CB-4EB3-8469-32A1EADE70ECQ37815027-58F0930C-29D2-4D66-8B35-6429DB9328A2Q37845312-A00C8158-621E-40B8-B3CA-C0FFC04E382DQ38068375-ADE8D122-3726-4A95-BF11-D7A5D76BAE99Q38167328-A8EF9C2C-9AA1-43FD-BEF6-1FF07A926C17Q38192507-DCC7C061-4E58-40EC-9632-1CE4077475E9Q38206273-EDC7C4C0-F96A-49D6-82BE-4005547C34DDQ38292852-3E75575B-DA9B-466C-8C46-836FB649E15EQ39838018-D45DF0C0-4381-479E-B7DE-9DBA21C20E38Q40589453-D5E69D45-0301-4C61-BFC6-343C7E2FEF5DQ40750506-017D4B39-CDB2-4D8A-B641-28FC1153F550Q41354358-FE35F037-A484-49D6-8F4C-AE17A876376EQ42026408-E68D19DC-3501-40AF-AE98-1C3A71B510CEQ44744242-100623CF-75DE-41CF-B4BE-66790ADA74E4Q46816097-1F1FE659-E9E6-4F24-9B32-D4E1B16F6550Q53573091-148640EB-4E89-420A-A033-6A46A0BB3B20Q57124745-8B8703B9-3DDE-4D81-A28B-4A9EC9608440
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Axillary recurrence after sentinel node biopsy.
@ast
Axillary recurrence after sentinel node biopsy.
@en
type
label
Axillary recurrence after sentinel node biopsy.
@ast
Axillary recurrence after sentinel node biopsy.
@en
prefLabel
Axillary recurrence after sentinel node biopsy.
@ast
Axillary recurrence after sentinel node biopsy.
@en
P2093
P1476
Axillary recurrence after sentinel node biopsy.
@en
P2093
Angel Nickolov
David J Winchester
Eihab Alwawi
Erika M Brinkmann
Ermilo Barrera
G M Schermerhorn
Jacqueline Sara Jeruss
Malcolm M Bilimoria
Stephen F Sener
P2888
P356
10.1007/S10434-004-1164-2
P577
2004-12-27T00:00:00Z